Evidence map›Paper›PMID 41914984›Full record

ArticleMolecular cancer research : MCR2026

Interaction of NDRG1 and TGM2 Modulates DNA Replication and Repair.

Hanna M Doh, Nina Kozlova, Kayla A Cruz, Taru Muranen

Abstract read
In one paragraph

Article in Molecular cancer research : MCR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hanna M DohDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.ORCID 0000-0003-0781-611X
Nina KozlovaDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.ORCID 0000-0002-4944-7917
Kayla A CruzDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.ORCID 0000-0001-8880-5804
Taru MuranenDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.ORCID 0000-0003-4158-9002

Funding

Role of extracellular matrix proteins and tumor stroma in DNA repair and cancer progressionR01CA258372 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MURANEN, TARU ELIISA · 2021 to 2025
$2.0M
American Cancer Society (ACS) RSG-19-0201-CSMCenter for Cancer Research (CCR) R01CA258372Ludwig Center at Harvard (Ludwig Center)NCI NIH HHS R01 CA258372Suomen Kulttuurirahasto (SKR)
6 · The paper itself

Abstract

In tumor cells, DNA replication is constantly challenged by endogenous and exogenous sources, referred to as replication stress, and various pathways have evolved to mitigate this stress in cancer. We recently identified an extracellular matrix (ECM)-induced DNA repair pathway involving N-myc downstream regulated gene 1 (NDRG1). Matrix-induced signaling results in NDRG1-dependent protection from chemotherapy-induced replication stress. To uncover further mechanistic details of NDRG1-mediated effects on DNA replication, we identified transglutaminase 2 (TGM2) as a novel NDRG1-binding partner. TGM2 is an acyltransferase that catalyzes Ca(2+)-dependent protein modifications. This interaction was enriched upon chemotherapy-induced replication stress and also upon ECM-induced signaling. Our data show that TGM2 depletion significantly slows replication fork progression, and this phenotype is dependent on TGM2 catalytic activity and its nuclear localization. Our study further identifies a putative NDRG1-TGM2 binding site and shows that the physical interaction between NDRG1 and TGM2 is required for efficient DNA replication. IMPLICATIONS: This study reveals a previously unrecognized nuclear function for NDRG1 and TGM2 in regulating DNA replication fork stability and recovery, and uncovers a stress-responsive mechanism that supports replication homeostasis in cancer cells and advances our understanding of how extracellular signals are integrated with replication and repair pathways.

Indexed as

Cell Cycle ProteinsDNA RepairDNA ReplicationGTP-Binding ProteinsIntracellular Signaling Peptides and ProteinsTransglutaminasesCell Line, TumorHumansN-myc Downstream-Regulated Gene 1 ProteinProtein BindingProtein Glutamine gamma Glutamyltransferase 2Signal TransductionCell Cycle ProteinsGTP-Binding ProteinsIntracellular Signaling Peptides and ProteinsN-myc Downstream-Regulated Gene 1 ProteinProtein Glutamine gamma Glutamyltransferase 2TGM2 protein, humanTransglutaminases

Identifiers

PMID41914984
PMCPMC13112271

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.